The government has announced “most-favored-nation” pricing agreements with 26 pharma companies. But the deals could stymie ...
By remaining shrouded in mystery, the MFN deals agreed to with drug makers reveal too little to tell how much money they’ll ...
These deals will require the companies to provide MFN prices to state Medicaid programmes nationally.
Public Citizen stressed that it supports efforts to lower drug costs for people in America, while caveating that the MFN deals as understood—and with added color from companies on the policy’s ...
The Chosun Ilbo on MSN
US drug policy may hike South Korea prices
A study has found that the U.S. Donald Trump administration’s "Most Favored Nation (MFN) drug pricing policy," aimed at ...
Trump says all 50 states have joined his Medicaid drug-pricing plan as Democrats seek to keep healthcare central in the ...
A consumer advocacy group has scrutinised some of the Most Favoured Nation (MFN) pricing deals the Trump administration has ...
Reference countries have limited room to simply raise their own drug budgets to absorb the pressure, the lead study author ...
On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services announced an agreement with the United Kingdom (U ...
Fact Sheet: President Donald J. Trump Announces Lower Drug Prices for All 50 State Medicaid Programs
Today, President Donald J. Trump announced that all 50 States’ Medicaid programs will benefit from lower prescription drug prices under his agreements with pharmaceutical manufacturers to match the ...
The government has announced pricing agreements with 26 pharma companies. But the deals could stymie other plans to lower the country’s drug spend.
But Congress should reject any effort to codify “Most Favored Nation” drug pricing—whether as a broad mandate, a limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results